STAAR Surgical
STAA
$42.62
Share price
-1.21%
Change (1 day)
-31.07%
Change (1 year)
STAAR Surgical (STAA) - Cash on Hand
Cash on Hand as of December 2023 : $0.22 B
According to STAAR Surgical's latest financial reports the company has $0.22 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
STAAR Surgical - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.22 B | 4.29% |
| 2022-12-31 | $0.21 B | 5.98% |
| 2021-12-31 | $0.19 B | 31% |
| 2020-12-31 | $0.15 B | 27.08% |
| 2019-12-31 | $0.11 B | 15.49% |
| 2018-12-31 | $0.10 B | 460.89% |
| 2017-12-31 | $18.52 M | 32.3% |
| 2016-12-31 | $13.99 M | 4.45% |
| 2015-12-31 | $13.4 M | 2.99% |
| 2014-12-31 | $13.01 M | -43.31% |
| 2013-12-31 | $22.95 M | 5.9% |
| 2012-12-31 | $21.67 M | 30.71% |
| 2011-12-31 | $16.58 M | 76.86% |
| 2010-12-31 | $9.37 M | 48.12% |
| 2009-12-31 | $6.33 M | 26.8% |
| 2008-12-31 | $4.99 M | -54.8% |
| 2007-12-31 | $11.04 M | 39.67% |
| 2006-12-31 | $7.9 M | -37.77% |
| 2005-12-31 | $12.7 M | 36.47% |
| 2004-12-31 | $9.31 M | 27.81% |
| 2003-12-31 | $7.28 M | 622.1% |
| 2002-12-31 | $1 M | 18.29% |
| 2001-12-31 | $0.85 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.69 B | 4,291.87% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $7.27 B | 3,197.75% | 🇺🇸 USA |
 Cooper Companies COO | $0.13 B | -38.75% | 🇺🇸 USA |
 Atrion ATRI | $6.25 M | -97.17% | 🇺🇸 USA |
 SurgePays SURG | $14.62 M | -93.38% | 🇺🇸 USA |